UNVERIFIEDSingle Source
Opinion: AI could revolutionize antibiotics — but the market is standing in the way
Stat News|3/5/2026
P
Pharma
167 stories tracked
Executive summary being generated...
Lindy
0
Breaking
0
Unverified
85
Activity (Last 30 Days)
1
2
7
5
3
2
2
5
1
5
3
4
2
6
4
4
4
2
3
4
1
3
2026-02-032026-03-05
Top Publishers
Stat News81 stories
Google News3 stories
South China Morning Post1 stories
Stories (Latest First)
UNVERIFIEDSingle Source
STAT+: FDA warns more telehealth firms about compounded GLP-1s
Stat News|3/4/2026
BREAKINGMulti-Source
STAT+: Moderna to pay Roivant up to $2.25 billion to settle patent lawsuit behind mRNA vaccines
Stat News|3/3/2026
UNVERIFIEDSingle Source
STAT+: Prime Medicine to seek approval for gene editing treatment after two-patient trial
Stat News|3/3/2026
UNVERIFIEDSingle Source
STAT+: CMS wants more drugmakers to join Medicaid ‘most-favored nations’ pilot
Stat News|3/3/2026
UNVERIFIEDSingle Source
STAT+: Pharmalittle: We’re reading about an FDA-UniQure feud, Pfizer’s ‘problem’ with the agency, and more
Stat News|3/3/2026
UNVERIFIEDSingle Source
STAT+: Pharmalittle: We’re reading about Trump’s MFN deals, 340B program controversies, and much more
Stat News|3/2/2026
UNVERIFIEDSingle Source
STAT+: Trump’s drive to get Europe to pay more for drugs creates uncertainty for countries, patients
Stat News|3/2/2026
UNVERIFIEDSingle Source
STAT+: Pharmalittle: We’re reading about FDA and a ‘smear campaign,’ Cigna buying a large pharmacy, and more
Stat News|2/27/2026
UNVERIFIEDSingle Source
STAT+: Pharmalittle: We’re reading about Trump’s drug-price claims, a Novo deal for obesity drugs, and more
Stat News|2/25/2026
UNVERIFIEDSingle Source
STAT+: Novo Nordisk strikes deal with U.S. startup to develop oral obesity, diabetes drugs
Stat News|2/25/2026
UNVERIFIEDSingle Source
STAT+: Drugmakers lay out their legal arguments against Trump’s drug pricing experiments
Stat News|2/24/2026
UNVERIFIEDSingle Source
STAT+: Pharmalittle: We’re reading about an FDA plan for ultra-rare drugs, Novo cutting GLP-1 drug prices, and more
Stat News|2/24/2026
UNVERIFIEDSingle Source
STAT+: Novo’s next-gen obesity drug stumbles in Lilly comparison study
Stat News|2/23/2026
UNVERIFIEDSingle Source
STAT+: Pharmalittle: We’re reading about pharma lobbying, a disappointing Novo clinical trial, and much more
Stat News|2/23/2026
UNVERIFIEDSingle Source
STAT+: Pharmalittle: We’re reading about an FDA official’s speech, a Grail cancer blood test, and much more
Stat News|2/20/2026
UNVERIFIEDSingle Source
STAT+: In first speech to her FDA staff, Høeg says she’ll scrutinize RSV shots and SSRIs in pregnancy
Stat News|2/19/2026
UNVERIFIEDSingle Source
STAT+: Pharmalittle: We’re reading about the FDA pushing OTC meds, its new trial standards, and much more
Stat News|2/19/2026
UNVERIFIEDSingle Source
Opinion: My biggest GLP-1 ethical problem: patients who don’t want to stop
Stat News|2/19/2026
UNVERIFIEDSingle Source
STAT+: At drugmakers’ forum, Oz gets a friendly embrace, while Makary faces tough questions
Stat News|2/17/2026
UNVERIFIEDSingle Source
STAT+: FDA’s rejection of Moderna threatens to stifle broader vaccine industry
Stat News|2/12/2026
UNVERIFIEDSingle Source
STAT+: Lawsuit against Hims & Hers should be ‘wake-up call’ for compounders, Novo chief counsel says
Stat News|2/9/2026
UNVERIFIEDSingle Source
STAT+: TrumpRx claims to offer the lowest prices. But many drugs have cheaper generics
Stat News|2/6/2026
UNVERIFIEDSingle Source
STAT+: White House looks for more drug pricing deals to add to TrumpRx
Stat News|2/6/2026
UNVERIFIEDSingle Source
STAT+: Pharmalittle: We’re reading about TrumpRx, Hims & Hers selling compounded Wegovy pill, and more
Stat News|2/6/2026
UNVERIFIEDSingle Source
Statins don’t cause most of the side effects on package warnings, study finds
Stat News|2/5/2026
UNVERIFIEDSingle Source
What to know about TrumpRx, the Trump administration’s prescription drug platform
Stat News|2/5/2026
UNVERIFIEDSingle Source
STAT+: Pharmalittle: We’re reading about Super Bowl drug ads, an FTC deal with Express Scripts, and more
Stat News|2/5/2026
UNVERIFIEDSingle Source
STAT+: Vertex’s CRISPR treatment for sickle cell disease hits unexpected roadblock
Stat News|2/5/2026
UNVERIFIEDSingle Source
STAT+: Pharmalittle: We’re reading about a Pfizer obesity pill, Florida’s failed drug importation plan, and more
Stat News|2/3/2026
UNVERIFIEDSingle Source
STAT+: Pfizer moves forward with its hopes for a monthly obesity drug
Stat News|2/3/2026
UNVERIFIEDSingle Source
STAT+: Pharmalittle: We’re reading about obesity drug sales, India’s biopharma research push, and more
Stat News|2/2/2026
UNVERIFIEDSingle Source
STAT+: Why Bristol Myers Squibb believes a decades-old drug can treat Alzheimer’s
Stat News|2/2/2026
UNVERIFIEDSingle Source
STAT+: As its immunology work draws attention, Sanofi also pushes forward in rare disease
Stat News|2/2/2026
UNVERIFIEDSingle Source
STAT+: Pharmalittle: We’re reading about pharma lobbying, an FDA gene-editing pathway, and more
Stat News|1/26/2026
UNVERIFIEDSingle Source
“I am very annoyed”: Pharma execs blast RFK Jr.’s attack on vaccines - Ars Technica
Google News|1/15/2026
UNVERIFIEDSingle Source
FDA tells Sanofi, GSK, AZ and CSL to include warnings for febrile seizures on flu shot labels - Fierce Pharma
Google News|1/15/2026